SATB1 and neoplasm: While no such effect was seen for MSI status and beta-catenin overexpression, SATB1 positivity was significantly associated with a shorter CSS in SATB2 negative tumours (p = 0.001, Figure 2B), in contrast to SATB2 positive tumours, where SATB1 was not significantly associated with survival (Figure 2C).